Brevan Howard Capital Management’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,960
Closed -$208K 2034
2026
Q1
$208K Sell
1,960
-221
-10% -$25.1K ﹤0.01% 1874
2025
Q4
$232K Sell
2,181
-853
-28% -$86.1K ﹤0.01% 1506
2025
Q3
$284K Buy
+3,034
New +$282K ﹤0.01% 1589
2024
Q3
Sell
-3,433
Closed -$286K 1110
2024
Q2
$286K Buy
+3,433
New +$286K ﹤0.01% 794
2024
Q1
Sell
-3,062
Closed -$253K 965
2023
Q4
$253K Buy
+3,062
New +$225K ﹤0.01% 789

Other funds holding ACA

Brevan Howard Capital Management's ACA Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Arcosa (ACA) in Q2 2026, closing a stake of 1,960 shares — an estimated $208K sold.

Brevan Howard Capital Management first reported a position in ACA in Q4 2023 and held it in 5 quarters. The position peaked at $286K in Q2 2024. 425 funds tracked by Wall St. Rank hold ACA as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Arcosa position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 1,960 Arcosa shares in Q2 2026, an estimated $208K.
  • Brevan Howard Capital Management first reported a position in Arcosa in Q4 2023 and held it in 5 quarters.
  • Brevan Howard Capital Management's Arcosa position peaked at $286K in Q2 2024.
  • 425 funds tracked by Wall St. Rank held Arcosa as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.